Harrow to Present at Three Investor Conferences in September in New York
Harrow, Inc. (HROW)
Last harrow, inc. earnings: 11/13 04:21 pm
Check Earnings Report
Company Research
Source: Business Wire
NASHVILLE, Tenn.--(BUSINESS WIRE)--Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced that management will participate in the following three investor conferences in September in New York:H.C. Wainwright 26th Annual Global Investment Conference (Lotte New York Palace Hotel)September 9-11, 2024Company will present at 8:00 a.m. ET on September 10, 2024Lake Street 8th Annual Best Ideas Growth Conference – Big 8 (The Yale Club)September 12, 20241x1 Meetings OnlyCantor 2024 Global Healthcare Conference (InterContinental New York Barclay Hotel)September 17-19, 2024Company will host a Fireside Chat at 2:30 p.m. ET on September 18, 2024The Company will conduct one-on-one meetings at each conference. Investors interested in meeting with management during conferences should contact their representative at each firm to request a meeting. To listen to the audio webcast of either the H.C. Wainwright or Cantor conferences, please visit the Company’s
Show less
Read more
Impact Snapshot
Event Time:
HROW
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HROW alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HROW alerts
High impacting Harrow, Inc. news events
Weekly update
A roundup of the hottest topics
HROW
News
- Harrow Partners with Asembia to Enhance Provider and Patient Experience Through Nationwide Digital Services and Hub Support for Harrow’s Branded Eyecare ProductsBusiness Wire
- Harrow To Report Third Quarter 2024 Financial Results After Market Close on November 13, 2024Business Wire
- Melt Pharmaceuticals Announces Dosing of Last Patient in Pivotal Phase 3 Study of Its Lead Product Candidate, MELT-300, for Needle- and Opioid-Free Sedation in Patients Undergoing Cataract SurgeryBusiness Wire
- Harrow, Inc. (NASDAQ: HROW) had its price target raised by analysts at Lake Street Capital from $45.00 to $55.00. They now have a "buy" rating on the stock.MarketBeat
- Harrow, Inc. (NASDAQ: HROW) had its price target raised by analysts at Craig Hallum from $45.00 to $65.00. They now have a "buy" rating on the stock.MarketBeat
HROW
Earnings
- 8/7/24 - Beat
HROW
Sec Filings
- 10/28/24 - Form 8-K
- 10/8/24 - Form SC
- 9/13/24 - Form 4
- HROW's page on the SEC website